Podcast


Presenter: Adrienne J Lindblad BSP ACPR PharmD James McCormack BSc (Pharm) Pharm D Mike Allan MD

Podcast: BS Medicine Episode #440 Putting the FUN in Fungi, Toenail Onychomycosis Treatments
0:00

In episode 440, Mike and James yet again invite Adrienne to go over all the evidence for treating toenail onychomycosis.  We find that ~ 40% more people get better on oral treatments than on placebo. For topicals the number is closer to 10%. Topicals should likely only be used if there is <40% nail involvement….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #615: Vape Expectations: Are electronic cigarettes the real deal for smoking cessation?

In episode 615, Mike and James revisit the evidence around using electronic cigarettes for smoking cessation. We look at smoking cessation rates between the use of e-cigarettes, nicotine-free e-cigarettes, nicotine…
Listen 0.5 credits available

BS Medicine Episode #614: Nipple Confusion or Nonsense? Pacifiers and Breastfeeding Duration

In episode 614, Mike and James discuss with Caitlin Finley the evidence around a very common primary care question. Does restricting early use of pacifiers result in higher rates of…
Listen 0.5 credits available

BS Medicine Episode #613: Doxycycline for post-exposure prophylaxis of sexually transmitted infections

In episode 613, Mike and James discuss with Jessica Kirkwood the evidence for post-exposure prophylaxis of sexually transmitted infections. We go over the 4 RCTs that have looked at the…
Listen 0.5 credits available

Presenter(s):

Adrienne J Lindblad BSP ACPR PharmD James McCormack BSc (Pharm) Pharm D Mike Allan MD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Adrienne J Lindblad BSP ACPR PharmD
  • James McCormack BSc (Pharm) Pharm D
  • Mike Allan MD

Spearkers do not have any conflicts of interest to declare.